Vinpocetine for injection is a vasodilator, which can inhibit phosphodiesterase activity, increase the role of c-GMP, the messenger of vascular smooth muscle relaxation, and selectively increase cerebral blood flow. In addition, it can inhibit platelet aggregation, reduce blood viscosity, enhance erythrocyte deformability, improve blood fluidity and microcirculation, promote brain tissue to absorb glucose, increase brain oxygen consumption and improve brain metabolism.

Puerarin for injection belongs to isoflavone. Has the effects of improving immunity, enhancing myocardial contractility, protecting myocardial cells, lowering blood pressure and preventing platelet aggregation.

The above two drugs are not routine drugs in the first line of hypertension guidelines, and short-term infusion therapy can not change the prognosis of hypertensive patients. Suggest patients to optimize their lifestyle, quit smoking, limit alcohol, limit salt and control fat; Moderate exercise; Relax and avoid emotional excitement and tension; Take drugs orally on time, regularly monitor blood pressure and recheck blood sugar, blood lipid, liver and kidney function, electrocardiogram and color Doppler echocardiography.